P2RY12 and chronic kidney disease: In this model, age, current smoking, previous CABG, chronic kidney disease, diameter of culprit lesion >3.0 mm and anterior MI were associated with higher rates of MACE, while the use of new P2Y12 inhibitors, statins, TIMI score 2/3 post PCI, and LVEF >40% at discharge were protectors.